Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer
Clinical trial NCT01262651 · COMPLETED
Trial details
- NCT number
- NCT01262651
- Sponsor
- GW Pharmaceuticals Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-25
- Primary completion
- 2015-07-02
- Enrollment
- 397
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.